Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE SPAIN EDITION 2026

Spain’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Spain. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Spain
ES
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
MEET THE COMPANIES

Explore Spain’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Life Sciences company highlights in Spain, snapshot 1 September 2026
Company
Splice Biosplice.bio$191.7M—24—
Minoryxminoryx.com$139.52M—33—
Sanifitsanifit.com$127.72M—31—
UDXuniversaldx.com$126.12M—61—
Oncomatryxoncomatryx.com$119.45M—19—
ORYZONoryzon.com$113.95M—43—
INBRAIN Neuroelectronicsinbrain-neuroelectronics.com$113.29M—52—
ARTHExarthexbiotech.com$107.84M—15—
IVB Wellness Labivbwellness.com—4 roles——
ALLOXallox.bio—2 roles——
DIVERSAdiversatechnologies.com—2 roles7—
Medcom Techmedcomtech.es—2 roles99—
Phibophibo.com—2 roles250—
diaterdiater.com—2 roles100—
Orikine Bioorikine.bio—1 roles——
sermessermescro.com—1 roles250—
Aldous Bioaldousbio.com——11—
Be Levelsbelevels.com——11—
Biorcebiorce.com————
Cortigentcortigent.com————
DNAGenicsdnagenics.com————
Exeltisexeltis.com——1,750—
Grifolsgrifols.com——18,309—
PharmaMarpharmamar.com——515—
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only
THE KEY SIGNALS

Life Sciences industry KPIs in Spain

A few useful ratios bring the size of this ecosystem into perspective.

1 September 2026
Hiring participation5.6%

43 of 771 tracked companies have open roles.

Funding participation34.4%

265 of 771 tracked companies have a recorded round.

Top 3 funding share18.5%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$562.05K

Midpoint of 552 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 18.5% of disclosed capital, while 65.6% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Spain life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Spain life sciences
$0$121.47M$242.94M$364.41M$485.88M2016: $117.5M20162017: $133.64M20172018: $88.54M20182019: $212.04M20192020: $212.01M20202021: $90.19M20212022: $221.31M20222023: $272.62M20232024: $142.87M20242025: $426.21M2025
View the numbers
Annual life sciences funding and company formation in Spain
YearFunding (USD)FoundedRaising
2016$117.5M4338
2017$133.64M3155
2018$88.54M4054
2019$212.04M4360
2020$212.01M3947
2021$90.19M3145
2022$221.31M2141
2023$272.62M1141
2024$142.87M1228
2025$426.21M324
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Splice Bio7.7%
  • Minoryx5.6%
  • Sanifit5.2%
  • Other companies81.5%

Funding by stage

647 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel147 22.7%
Series A–B91 14.1%
Series C+ / PE12 1.9%
Grants, debt & other397 61.4%

Recent recorded rounds

Latest recorded rounds · USD
8 rounds

Swipe or scroll horizontally to browse.

Seed05/2026
Tolemy Bio $1.65M

Backed by Norrsken Evolve and Big Sur Ventures and others.

Grant (prize money)05/2026
Kanara $580.72K

Backed by Europa.

Series C04/2026
Peptomyc $5.84M

Backed by Alta Life Sciences and Aurora Science and others.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series D06/2019
Sanifitsanifit.com$82.1M

Backed by Caixa Capital Risc and Columbus Venture Partners and others.

Series C05/2022
Minoryxminoryx.com$54.89M

Backed by Columbus Venture Partners and Caixa Capital Risc and others.

Series A01/2025
Quibimquibim.com$50.22M

Backed by Asabys Partners and Buenavista Equity Partners and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Expand panel +

Annual accounts availability

No reviewed exact national-ID connector has yet been qualified for Spain; this is a checked implementation boundary, not evidence that filings are absent.; No reviewed exact national-ID connector has yet been qualified for Spain; this is a checked implementation boundary, not evidence that filings are absent.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Spain companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

36 of these companies (4.7%) publish at least one Android app — 60 apps in all, carrying 228.3K installs between them.

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q1–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Wearable Technology656.1KBabyFever 43.7K
Life Sciences Tech1955.5KFarmatic APProx - Mi Farmacia 24.9K
Pediatrics343.8KMarsi Connect 57
Online Mom & Baby Care243.8K4Liv 42
Genomics922.9KADNTRO GENETICS 10.6K
Surgical Instruments317.3KAirtraq Mobile 7.7K
Healthcare Booking Platforms317.1KCardioCity112 5.8K
Healthcare It915.8KConox View 5.1K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2022Q4: 12022Q4: 02022Q42023Q1: 12023Q1: 02023Q12024Q1: 42024Q1: 12024Q12024Q2: 22024Q2: 02024Q22024Q3: 12024Q3: 52024Q32024Q4: 32024Q4: 12024Q42025Q1: 42025Q1: 32025Q12025Q2: 12025Q2: 12025Q22025Q3: 12025Q3: 52025Q32025Q4: 22025Q4: 142025Q42026Q1: 22026Q1: 122026Q1

Darker bars are new releases, lighter bars apps updated. 40 of 60 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The Spain life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech499
Medical devices167
Deep tech153
Healthtech148
Biopharmaceuticals121
Enterprise software109
Consumer digital106
In vitro diagnostics51
Saas46
Healthtech saas40
Life sciences analytics26
Nutritional formula26

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

499companies
6.2%have hiring activity

31 companies hiring · $2.3B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce368
E-commerce - product294
Subscription236
Fee-for-service145
Commission on transaction19
Advertising14
E-commerce - service8
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Funding roundsgrifols.com ↗

The new financing package is more than 5.3 billion dollars equivalent and is structured into three sections: a pre-acute stalt denominated in US dollars for 2 billion dollars, a euro tranche of 1.25 billion euros and a cash flow of cash with total commitments of approximately 2.06 billion dollars.

Mergers & acquisitionshealthincode.com ↗

Mérieux Equity Partners acquires a significant minority stake in Health in Code

Funding roundsaptadeltx.com ↗

The biotechnology company, based in the Science Park of the University of Barcelona (PCB), has closed a bridge round of two million euros.

Mergers & acquisitionssermescro.com ↗

Spanish venture capital managers Abe Capital Partners and Columbus Venture Partners have agreed to acquire a majority stake in Sermes, a company specializing in contract research (CRO) dedicated to the comprehensive management of clinical trials and associated services.

Funding roundspharmacelera.com ↗

The €6 million ($7.1 million) financing round was led by Heran Partners with participation from Clave Capital, Inveready, and Bio&Tech Smart Capital.

Funding roundsbiorce.com ↗

Biorce starts, which at the beginning of 2026 raised 44.6 million euros (52.5 million US$).

Funding roundsuniversaldx.com ↗

Universal Diagnostics closed a €62M funding round with €30M from the Spanish government through SETT.

Funding roundstetraneuron.com ↗

The biotechnology company Tetraneuron completes a funding round of 5 million euros that will allow to bring its innovative gene therapy against Alzheimer's disease to the clinical development phase.

Mergers & acquisitionssuannutra.com ↗

Carbyne Equity Partners and SuanNutra: In December, private equity investment firm Carbyne acquired SuanNutra, the nutraceutical ingredients business of Suanfarma, a portfolio company of ARCHIMED.

Full recorded event mix

Top 10 categories among 118 recorded events in the 24-month window.

Funding rounds
48
Leadership moves
16
Mergers & acquisitions
13
Capital infusions
8
Company announcements
8
Board Updates
7
IPO activity
4
Earnings
4
Buyback
2
Fundraising
2
5 activity cards

Swipe or scroll horizontally to browse.

IPO pipeline

2 companies with recorded IPO activity

Grifols ↗

IPO2 reports

Cortigent ↗

IPO · NYSE American2 reports

Leadership moves

3 tracked people moves

ORYZON ↗
Rolando Gutierrez-Esteinou, MD

Appointment Chief Medical Officer, CNS Programs

Orikine Bio ↗
Larry Edwards

Appointment chairman of the board

Miles Gerson

Appointment Independent Chairman of its Board of Directors

Contract wins

2 recorded customer wins

Grifols ↗

Customer: Ralledor HoldingPharmaceutical

PharmaMar ↗

Customer: chugai pharmaceutical

Regulatory events

6 recorded events

Grifols ↗

approved for public sale

PharmaMar ↗

authorization of share distributionNational Securities Market Commission (CNMV)

PharmaMar ↗

informed regulator about delivery planNational Securities Market Commission (CNMV)

Grifols ↗

rejection of Brookfield OPANational Securities Market Commission (CNMV)

Litigation

2 tracked suits

Company
grifols v general industrial partners

multimillion dollar compensationCivil ·

Company
grifols v Gotham City Research

financial misrepresentation allegationsCivil · Ongoing

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
Abe Capital Partners and Columbus Venture Partners→sermes ↗Completed2026-02-26Not stated in snapshot
Mérieux Equity Partners→Health in Code ↗Completed2026-02-13Not stated in snapshot
church & dwight→Touchland ↗Announced2026-01-27$880.0M
Carbyne Equity Partners→SUANNUTRA ↗Pending2025-12-16Not stated in snapshot
Grifols→biotestCompleted2025-06-11Not stated in snapshot
Churcc & Dwight→Touchland ↗Announced2025-05-18Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

1 postings in the preceding 12 months. The full 6-posting snapshot covers 6 employers.

Expand panel +

Most advertised job titles

Life Science Inside Sales Representative (M/F/D)1
Sales Manager Life Sciences Iberia1
It & Compliance Consultant Life Sciences (Remote)1
Midlevel/Senior Associate Corporate & Business Transactions Life Sciences1
Business Development Director (Life Sciences)1
Sr Analyst, Buyer Edwards Lifesciences1
0 internship postings

1 tracked postings mention remote work.

The seniority mix

4 postings specify a level.

manager
2
senior
2
unspecified
2
THE PEOPLE BUILDING THE FIELD

Founders and leaders

606 founders and chief executives across 407 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

55 profiles with education records.

Universitat de Barcelona
7
University of Cambridge
7
Universitat Politècnica de Catalunya
6
IE Business School
5
Harvard Business School
5
Harvard University
4
University of Oxford
4
Universidad Politécnica de Madrid
3

Prior employers

4 profiles with prior-work records.

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

326,307 articles in the measured 12-month window.

Expand panel +
326,307articles in the measured year
54,921articles in 2026Q1
42.5%positive tone in the latest complete year

News volume trends

Life Sciences coverage across Spain · articles per complete quarter

047,31694,632141,949189,2652021Q2: 46,8322021Q22021Q3: 51,1722021Q4: 41,7522022Q1: 47,3972022Q2: 52,9572022Q22022Q3: 52,8432022Q4: 64,2192023Q1: 65,4012023Q2: 61,6052023Q22023Q3: 69,9142023Q4: 55,6772024Q1: 68,0752024Q2: 77,9322024Q22024Q3: 84,3152024Q4: 81,3942025Q1: 98,7812025Q2: 68,5132025Q22025Q3: 164,5782025Q4: 44,3712026Q1: 54,9212026Q1
View quarterly article counts
QuarterArticles
2021Q246,832
2021Q351,172
2021Q441,752
2022Q147,397
2022Q252,957
2022Q352,843
2022Q464,219
2023Q165,401
2023Q261,605
2023Q369,914
2023Q455,677
2024Q168,075
2024Q277,932
2024Q384,315
2024Q481,394
2025Q198,781
2025Q268,513
2025Q3164,578
2025Q444,371
2026Q154,921

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
76,372 positive · 33,550 neutral · 39,757 negative
2022
110,561 positive · 51,553 neutral · 54,964 negative
2023
131,178 positive · 64,579 neutral · 56,481 negative
2024
146,482 positive · 99,291 neutral · 65,395 negative
2025
159,847 positive · 152,608 neutral · 63,335 negative

Leading coverage topics

Life Sciences coverage across Spain · ranked by full-period article count.

Geopolitical Disputes And Contested Areas301,108 articles in the full recorded period
108,140 recent · 81,433 prior
International And Transnational Geographic Entities301,103 articles in the full recorded period
108,143 recent · 81,435 prior
Administrative And Political Subdivisions301,072 articles in the full recorded period
108,128 recent · 81,429 prior
International Sports Competitions39,830 articles in the full recorded period
6,811 recent · 10,305 prior
Sports History And Legacy Stories26,401 articles in the full recorded period
19,506 recent · 2,557 prior
Sportsmanship And Ethics In Sports24,048 articles in the full recorded period
18,560 recent · 1,358 prior
Professional League Updates23,140 articles in the full recorded period
5,128 recent · 4,976 prior
Olympic Games Coverage17,635 articles in the full recorded period
1,990 recent · 5,596 prior
Championship Event Highlights16,392 articles in the full recorded period
3,288 recent · 4,166 prior
International Political Relations15,761 articles in the full recorded period
4,706 recent · 3,628 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Life Sciences coverage across Spain

KeywordRecentPriorChange
countries4,2501,920121%
geopolitical alliances86151767%
women\'s champions league75852445%
foreign policy analysis695278150%
diplomatic strategies62443643%
multilateral diplomacy609271125%
fire impact study517147252%
diplomatic engagements39226747%
extreme temperature advisory391131198%
wildfire control379125203%
europa league5741,665-66%
olympic trials1681,601-90%
olympic team selections2351,426-84%
ronaldo5931,078-45%
final match3501,061-67%

Event and signal lenses

Life Sciences coverage across Spain

All complete annual cohorts shown
Rising

Regulatory Risk

592,116 classified articles

territories, disputed islands, countries

13.1% critical · 11.7% positive
Rising

Funding Momentum

43,611 classified articles

club valuation, quarterfinals, world cup

32.3% critical · 43.6% positive
Rising

Growth

88,811 classified articles

gdp growth rate, league expansion news, gdp acceleration

25.8% critical · 48.6% positive

Life Sciences coverage across Spain. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
—India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Sustainable Biofuel and Biomass ProductionCommon problems researchers identify · 01

Sustainable Biofuel and Biomass Production

781 papers

17.3% of this theme group

Researchers discuss challenges in using microbes and plants for renewable fuels and biorefinery processes.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.6
202359.3
202461.9
202567.0
Food Safety and Processing RisksCommon problems researchers identify · 02

Food Safety and Processing Risks

757 papers

16.8% of this theme group

Papers highlight microbial hazards and nutritional impacts linked to food manufacturing and human health.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202270.2
202372.4
202477.4
202599.2
Gene Expression and mRNA TherapeuticsCommon problems researchers identify · 03

Gene Expression and mRNA Therapeutics

711 papers

15.8% of this theme group

Studies examine cellular and molecular hurdles in mRNA delivery, gene regulation, and related biomedical applications.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222510.1
20232495.8
20242199.0
20251697.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Research points to difficulties in improving plant nutrient uptake and breeding for resilient, high‑yield crops.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221635.2
20231667.4
20241799.9
20252026.9
Plant Disease Management StrategiesCommon problems researchers identify · 05

Plant Disease Management Strategies

691 papers

15.3% of this theme group

Works address obstacles in controlling pathogens, integrating pest management, and enhancing host resistance.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.8
202329.2
202427.8
202537.2
Antimicrobial Resistance Across SectorsCommon problems researchers identify · 06

Antimicrobial Resistance Across Sectors

447 papers

9.9% of this theme group

Literature surveys the spread of drug‑resistant microbes in humans, livestock, and the environment.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Miscellaneous Biological and Legal TopicsCommon problems researchers identify · 07

Miscellaneous Biological and Legal Topics

423 papers

9.4% of this theme group

Papers cover a range of unrelated subjects, from academic writing styles to civil justice frameworks.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.4
202321.9
202417.8
202512.5

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Toxicity and Oxidative Stress AssaysCautions · 01

Cellular Toxicity and Oxidative Stress Assays

379 papers

21.5% of this theme group

Authors caution about interpreting in‑vitro and in‑vivo toxicity data due to stress‑related artifacts.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221034.9
20231110.3
2024911.7
2025818.5
Genomic Selection and Trait Prediction LimitsCautions · 02

Genomic Selection and Trait Prediction Limits

257 papers

14.6% of this theme group

Studies warn of uncertainties when applying genomic tools to plant breeding and animal production.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221437.3
20231478.4
20241637.4
20251817.4
Feed Additives and Health Impact UncertaintiesCautions · 03

Feed Additives and Health Impact Uncertainties

245 papers

13.9% of this theme group

Research highlights the need for careful evaluation of novel feed compounds on animal and human health.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202222.2
202320.9
202417.3
202518.2
Food Contaminants and Regulatory GapsCautions · 04

Food Contaminants and Regulatory Gaps

240 papers

13.6% of this theme group

Papers emphasize potential safety issues with emerging food additives and the need for clearer regulations.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202291.3
202389.1
202495.4
2025105.8
DNA Damage and Repair Mechanism AmbiguitiesCautions · 05

DNA Damage and Repair Mechanism Ambiguities

239 papers

13.5% of this theme group

Works point out complexities in interpreting gene‑damage markers and repair pathways in disease contexts.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222415.6
20232417.4
20242125.5
20251613.8
Co‑Selection of Resistance TraitsCautions · 06

Co‑Selection of Resistance Traits

206 papers

11.7% of this theme group

Authors caution that antimicrobial use can drive linked resistance to biocides and heavy metals.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Pesticide Resistance Management ChallengesCautions · 07

Pesticide Resistance Management Challenges

199 papers

11.3% of this theme group

Literature discusses difficulties in designing dose strategies to curb evolving pesticide resistance.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.9
202365.3
202466.9
202575.8

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Advanced Antibody and Imaging TechniquesOpportunities · 01

Advanced Antibody and Imaging Techniques

1,044 papers

17.4% of this theme group

Opportunities arise from novel antibody formats and fluorescence methods for in‑vivo cellular analysis.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022561.4
2023615.1
2024467.1
2025455.3
Gene Modulation for Disease InterventionOpportunities · 02

Gene Modulation for Disease Intervention

1,032 papers

17.2% of this theme group

Research explores therapeutic potential of gene knockdown, apoptosis control, and cell‑growth regulation.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022364.0
2023394.7
2024257.4
2025261.8
Functional Plant‑Based FoodsOpportunities · 03

Functional Plant‑Based Foods

878 papers

14.6% of this theme group

Studies highlight emerging health‑benefiting ingredients and antioxidant compounds in sustainable diets.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202326.2
202427.1
202545.2
Epigenetic and RNA‑Based DiagnosticsOpportunities · 04

Epigenetic and RNA‑Based Diagnostics

823 papers

13.7% of this theme group

Papers present innovative uses of DNA methylation and messenger RNA markers for disease detection.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222397.7
20232377.6
20242114.7
20251613.7
Novel Antimicrobials and Postbiotic SolutionsOpportunities · 05

Novel Antimicrobials and Postbiotic Solutions

809 papers

13.5% of this theme group

Research points to plant‑derived agents and microbial metabolites as new tools against resistance.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.4
2024554.5
2025649.8
Genetic Improvement of Crop TraitsOpportunities · 06

Genetic Improvement of Crop Traits

717 papers

11.9% of this theme group

Works focus on leveraging germplasm and quantitative trait loci to boost yield and quality.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202253.0
202345.3
202439.2
202540.8
Sustainable Biomass Conversion TechnologiesOpportunities · 07

Sustainable Biomass Conversion Technologies

697 papers

11.6% of this theme group

Studies identify microbial fermentation and by‑product valorization as routes to greener biofuels.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221514.8
20231566.1
20241742.6
20251980.2

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.2%
Promising30.4%37.2%
Breakthrough14.1%26.8%
Problem-identifying8.3%9.6%
Cautionary3.5%4.5%
Comparative2.4%3.9%
Critical1.0%0.9%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Life Sciences patents in Spain

Published patent filings in the recorded source window.

Expand panel +
8,489filings 2016–2025
7,231assignees
969peak annual filings

Filing momentum

02795578361,1142016: 81920162017: 9692018: 83720182019: 8282020: 84420202021: 9232022: 78220222023: 8302024: 83520242025: 8222025

Who files the most

Consejo Superior Investigacion
2,204
UNIV Madrid Autonoma
427
Grifols
395
UNIV Santiago Compostela
319
UNIV Barcelona Autonoma
303
Proyecto Biomedicina CIMA SL
296
INST Catalana Recerca Estudis Avanca
282
Lipotec
253
GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Life Sciences in Spain: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 1 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon